Neurology News

Genentech announced positive results from its global phase 2 study evaluating the investigational oral Bruton’s tyrosine kinase inhibitor fenebrutinib in adults with relapsing forms of MS.

CHICAGO — While there is significant interest in the Black community to learn about Parkinson’s disease research and study participation, interventions are needed to reduce recruitment barriers and improve access to information.

Sunosi, Wakix and armodafinil-modafinil reduced excessive daytime sleepiness in patients with obstructive sleep apnea who are already receiving conventional therapy, with Sunosi being “likely superior,” according to researchers.

CHICAGO — Active electrode placement in the right subthalamic nucleus in deep brain stimulation was associated with weight gain in patients with Parkinson’s disease, with lesser gain reported with medially placed electrodes.

CHICAGO — Quetiapine remains the drug of choice for psychosis in patients with Parkinson’s disease dementia and dementia with Lewy bodies, per data at the International Association of Parkinsonism and Related Disorders World Congress.

CHICAGO — Patients with tardive dyskinesia reported greater impact on quality of life than health care providers, according to a poster at the International Association of Parkinsonism and Related Disorders World Congress.

Patients with COPD first visiting the ED with acute exacerbations faced greater risks for dementia with ICU admission vs. hospital admission or exclusive ED care, according to study results published in BMC Pulmonary Medicine.

Abbott has announced the FDA expanded the indication of its BurstDR spinal cord stimulation devices for treating chronic back pain in those who have not had or are ineligible for back surgery.

CHICAGO — Tributyrin supplementation may have a beneficial effect on motor symptoms and inflammatory markers in Parkinson’s disease, according to data at the International Association of Parkinsonism and Related Disorders World Congress.

Compared with obstructive sleep apnea, veterans with central sleep apnea had greater mortality rates, shorter time to death and higher mortality hazard, according to study results published in Annals of the American Thoracic Society.